Oncology Chimeric antigen receptor T-cells: Emerging uses and future ... Genetic engineering technologies allow for the creation of custom-made cells that can have transformative effects on human health.
News Hope for lupus sufferers with Feinstein Institutes-led phase... Findings from the litifilimab trial, undertaken by Northwell Health’s Division of Rheumatology and The Feinstein Institutes for Medical Research, have been published in the New England
Events Partner Content Welcome to the 6th Complement-based Drug Development Summit ... Decipher Complement Pathway Intricacies, Validate Pathway Activation Assays & Discover Next-Generation Complement-Targeted Approaches that are
Events Partner Content 2nd Integrin-Targeted Drug Development Summit In collaboration with leading integrin drug developers, including Genentech, 7 Hills Pharm
Events Partner Content 3rd B & T Cell-Mediated Autoimmune Disease Drug Development ... Industry-led forum focused on B & T Cell Collaboration
Events Partner Content 4th Antigen Specific Immune Tolerance Summit The 4th Antigen Specific Immune Tolerance Digital Summit (ASIT) brings together industry representatives from the fields of autoimmun
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.